Show simple item record

Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l -methionine, 67 Ga-citrate, and 125 I-HSA

dc.contributor.authorFisher, Susan J.en_US
dc.contributor.authorWahl, Richard L.en_US
dc.contributor.authorSugawara, Yoshifumien_US
dc.contributor.authorBrown, Raya S.en_US
dc.contributor.authorGutowski, Tomasz D.en_US
dc.date.accessioned2006-09-08T19:56:41Z
dc.date.available2006-09-08T19:56:41Z
dc.date.issued1999-04en_US
dc.identifier.citationSugawara, Yoshifumi; Gutowski, Tomasz D.; Fisher, Susan J.; Brown, Raya S.; Wahl, Richard L.; (1999). "Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l -methionine, 67 Ga-citrate, and 125 I-HSA." European Journal of Nuclear Medicine 26(4): 333-341. <http://hdl.handle.net/2027.42/42076>en_US
dc.identifier.issn0340-6997en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/42076
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10199938&dopt=citationen_US
dc.description.abstractThe purpose of this study was to evaluate the localization of positron emission tomography (PET) tracers [2-deoxy-2-fluoro- d -glucose (FDG), thymidine, and l -methionine] in sites of bacterial infection, and to contrast this with that of other tracers. The left calf muscles of rats were infected with a suspension of Escherichia coli and the biodistribution of 18 F- or 3 H-FDG, 3 H-thymidine, l - 11 C- or 3 H-methionine, gallium-67 citrate ( 67 Ga-citrate) and iodine-125 human serum albumin ( 125 I-HSA) was determined in these animals. 3 H-FDG uptake in the infectious foci was evaluated by autoradiography of histological sections. Although 18 F-FDG, 67 Ga-citrate, and 125 I-HSA showed comparatively high uptake in the infected muscle [the percentage activity of injected dose (ID) per gram of tissue normalized for rat weight in kilogram (%ID/g)×kg at 2 h postinjection was as follows: 18 F-FDG, 0.184±0.026 to 0.218±0.046; 67 Ga-citrate, 0.221±0.016; 125 I-HSA, 0.198±0.019], the infected muscle to blood ratio was much higher for 18 F-FDG than for 67 Ga-citrate or 125 I-HSA ( 18 F-FDG, 10.31±0.76 to 14.89±2.26; 67 Ga-citrate, 1.24±0.67; 125 I-HSA, 0.20±0.02). The draining reactive lymph nodes also showed higher accumulation of 18 F-FDG than of 67 Ga-citrate or 125 I-HSA. The uptake of 3 H-thymidine and l - 11 C- or 3 H-methionine in the infected muscle was lower than that of 18 F- or 3 H-FDG (at 2 h postinjection, 3 H-thymidine = 0.039±0.005 and L- 3 H-methionine = 0.063±0.007 (%ID/g)×kg. Autoradiographs showed that the highest 3 H-FDG uptake was seen in the area of inflammatory cell infiltration surrounding the necrotic region. In conclusion, 18 F-FDG, which rapidly accumulates in sites of bacterial infection and in reactive lymph nodes with a high target to background ratio, appears to be a promising infection detection agent.en_US
dc.format.extent220678 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag Berlin Heidelbergen_US
dc.subject.otherThymidineen_US
dc.subject.otherFluorodeoxyglucoseen_US
dc.subject.otherGallium-67 Citrateen_US
dc.subject.otherL-Methionineen_US
dc.subject.otherLegacyen_US
dc.subject.otherKey Words: Bacterial Infectionen_US
dc.titleUptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, l -methionine, 67 Ga-citrate, and 125 I-HSAen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelRadiologyen_US
dc.subject.hlbsecondlevelPhysicsen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan, USA, USen_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan, USA, USen_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan, USA, USen_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan, USA, USen_US
dc.contributor.affiliationumDivision of Nuclear Medicine, Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Michigan, USA, USen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid10199938en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/42076/1/259-26-4-333_90260333.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/s002590050395en_US
dc.identifier.sourceEuropean Journal of Nuclear Medicineen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.